Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Like
Tweet
Print
Thom Lysen
PHARMO Institute for Drug Outcomes Research, Netherlands
Poster(s):
(344) Interim results from the VAC4EU Post-Authorization Safety Study (PASS) among recipients of the Pfizer-BioNTech COVID-19 (Comirnaty®) vaccine in Europe
Tuesday, August 27, 2024
8:00 AM – 6:00 PM
CEST
(359) Safety of the Janssen COVID-19 vaccine (JCOVDEN) using VAC4EU European Healthcare Data Sources: Methods and Results of the Second Study Feasibility Assessment
Tuesday, August 27, 2024
8:00 AM – 6:00 PM
CEST
